Designing KRIs and QTLs That Drive Real Signal Detection in Clinical Trials
Designing KRIs and QTLs That Drive Real Signal Detection in Clinical Trials Designing KRIs and QTLs That Drive Real Signal Detection in Clinical Trials In the context of clinical trials and risk-based monitoring (RBM), the concepts of Key Risk Indicators (KRIs) and Quality Tolerance Limits (QTLs) are indispensable for ensuring effective signal detection. By integrating…
Read More “Designing KRIs and QTLs That Drive Real Signal Detection in Clinical Trials” »